Skip to content

RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment

An International Registry in Essential Hypertension

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00258921
Acronym
RIAT
Enrollment
31870
Registered
2005-11-28
Start date
2004-03-31
Completion date
2006-07-31
Last updated
2007-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

To support physicians in their active management of hypertensive patients. By targeting specific systolic and diastolic blood pressure (BP) figures physicians will closely monitor the BP values and as such will have an individualized control of the treatment in each patient.

Interventions

None listed

Sponsors

Bristol-Myers Squibb
CollaboratorINDUSTRY
Sanofi
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

The following information on clinical trials is provided for information purposes only to allow patients and physicians to have an initial discussion about the trial. This information is not intended to be complete information about the trial, to contain all considerations that may be relevant to potential participation in the trial, or to replace the advice of a personal physician or health professional. Main criteria are listed hereafter: Inclusion Criteria: * Adult hypertensive * Either newly diagnosed and untreated * or previously treated and uncontrolled Patients of both sexes with essential hypertension

Exclusion criteria

* Known secondary hypertension * Known secondary curable hypertension (i.e. pheochromocytoma, aldosterone producing adenoma, Cushing disease). Patients with renal disease are not excluded.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026